One Global Service Provider Ltd (514330)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, One Global's revenue was ₹103 Cr (+16.8% year on year, -23.3% on the previous quarter), and net profit ₹14.3 Cr (+43.0% year on year); the operating margin was 18.7%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹103 | +16.8% | -23.3% |
| Operating profit | ₹19.2 | +47.5% | -20.1% |
| Net profit | ₹14.3 | +43.0% | -20.6% |
| EPS (₹) | 7.32 | -47.0% | -21.4% |
| Operating margin | 18.7% | — | — |
📢 Recent Corporate Announcements
One Global Service Provider Ltd has secured in-principle approval from BSE Limited for the preferential allotment of 7,06,068 equity shares to the non-promoter category pursuant to a share swap. The issue is priced at not less than ₹558.93 per share (face value ₹10), implying an aggregate transaction value of approximately ₹39.46 crore. Relative to the company's market cap of ₹1,024 crore, the equity dilution represents roughly 3.6% of the current market value. The swap price of ₹558.93 represents a 7.2% premium over the current market price of ₹521.50.
- Received BSE in-principle approval to issue 7,06,068 equity shares of ₹10 face value each
- Minimum issue price fixed at ₹558.93 per share, representing a premium over current market price of ₹521.50
- Implied transaction size stands at approximately ₹39.46 crore
- Shares are being issued to non-promoter category on a preferential basis pursuant to a share swap
One Global Service Provider Limited has issued a corrigendum to its 34th AGM notice regarding a preferential equity issue for acquiring stakes in Matrix Labs Diagnocare and Matrix Labs Private Limited. Following BSE observations, the issue price was revised upwards from ₹553 per share to ₹560.13 for MLDPL and ₹558.99 for MLPL. The total non-cash consideration remains unchanged at ₹39.54 Cr (₹35.98 Cr for MLDPL and ₹3.56 Cr for MLPL), resulting in a slight reduction in allotted shares to 7,06,068 shares. Post-allotment, promoter holding will dilute from 68.40% to 66.01%.
- Preferential issue price revised upwards from ₹553.00 to ₹560.13 per share for MLDPL and ₹558.99 for MLPL based on BSE advice.
- Total consideration stays unchanged at ₹35,97,81,800 for MLDPL and ₹3,56,35,320 for MLPL (combined ~₹39.54 Cr).
- Total shares to be issued reduced slightly to 7,06,068 equity shares for acquisition consideration other than cash.
- Promoter shareholding post-issue reduces from 68.40% to 66.01%, diluting by 239 bps.
- E-voting for the 34th AGM is scheduled from September 25 to September 28, 2026, ahead of the AGM on September 29, 2026.
One Global Service Provider Limited has dispatched communication letters to shareholders whose email addresses are not registered, providing access to the FY 2025-26 Annual Report and Notice of the 34th Annual General Meeting (AGM). The AGM is scheduled for September 29, 2026, via Video Conferencing. The company confirmed a final dividend recommendation of Re. 1/- per equity share, with the record date set for September 22, 2026. If approved, the dividend will be disbursed on or before October 28, 2026.
- 34th AGM scheduled for Tuesday, 29th September, 2026 at 02:00 PM IST via VC/OAVM
- Final dividend proposed at Re. 1/- per equity share for FY 2025-26
- Record date for dividend entitlement and e-voting cut-off is Tuesday, 22nd September, 2026
- E-voting window opens on 25th September, 2026 (09:00 AM) and closes on 28th September, 2026 (05:00 PM)
- Dividend payout date slated on or before Wednesday, 28th October, 2026
One Global Service Provider Limited has issued the notice for its 34th Annual General Meeting (AGM) scheduled for Tuesday, September 29, 2026, via video conferencing. The company has fixed September 22, 2026, as the record date and cut-off date for eligibility to receive a final dividend of Re. 1/- per equity share of face value Rs 10. Key special business includes seeking shareholder approval for an enabling borrowing limit under Section 180(1)(c) of up to Rs 1,000 Crore (compared to current debt of Rs 0 Cr and net worth of Rs 142 Cr). Other agenda items include the re-appointment of the Managing Director and a 5-year second term for statutory auditors M/s S D P M & Co.
- Final dividend recommended at Re. 1/- per equity share of face value Rs 10 for FY 2025-26
- Record date and remote e-voting cut-off fixed for Tuesday, September 22, 2026
- 34th AGM to be held on Tuesday, September 29, 2026, at 2:00 PM IST via Video Conferencing
- Remote e-voting window active from September 25, 2026 (9:00 AM) to September 28, 2026 (5:00 PM)
- Proposed enabling borrowing limit resolution under Section 180(1)(c) up to Rs 1,000 Crore
One Global Service Provider Limited has submitted its Annual Report and Notice for the 34th Annual General Meeting scheduled for September 29, 2026. The Board has recommended a final dividend of Re. 1 per equity share (face value Rs. 10), with September 22, 2026 fixed as the record date. The company is also seeking shareholder approval for an enabling borrowing limit of up to Rs. 1,000 Crore under Section 180(1)(c) (compared to its current net worth of Rs. 142 Cr and zero debt). Other routine business includes the re-appointment of statutory auditors for a second 5-year term.
- 34th Annual General Meeting convened for Tuesday, 29th September, 2026 via VC/OAVM.
- Recommended final dividend of Re. 1/- per equity share (face value Rs. 10/-).
- Record date and cut-off date for dividend and e-voting set as Tuesday, 22nd September, 2026.
- Seeking shareholder approval to increase overall borrowing limits up to Rs. 1,000 Crore under Section 180(1)(c).
- Proposed re-appointment of M/s. S D P M & Co. as Statutory Auditors for a second term of 5 consecutive years.
One Global Service Provider Ltd has scheduled a Board of Directors meeting on September 3, 2026, to consider and approve a proposed fundraise via the issuance of equity shares or other securities on a preferential basis. The Board will also review and approve the draft Notice for the upcoming Annual General Meeting (AGM). Quantums, issue price, and target investor identities are not disclosed at this stage and remain subject to shareholder and regulatory approvals. The company currently holds a market capitalization of ₹1,067 Cr with nil debt.
- Board meeting scheduled for September 3, 2026, to evaluate preferential issue of securities
- Fundraise subject to applicable SEBI ICDR regulations and shareholder approval
- AGM date, timing, and venue to be finalized in the same meeting
- Trading window closed with immediate effect until 48 hours post board meeting conclusion
One Global Service Provider has appointed CA Niraj Chordia as Chief Financial Officer and Key Managerial Personnel effective August 14, 2026, bringing over 18 years of finance and compliance experience. In the same meeting, internal auditor M/s Rushil Soni & Co. resigned due to professional preoccupations. Additionally, the company approved its Q1 FY27 results, reporting standalone revenue of ₹102.77 Cr (up 17.0% YoY) and net profit of ₹14.30 Cr (up 45.6% YoY from ₹9.82 Cr).
- Appointed CA Niraj Chordia as Chief Financial Officer and Key Managerial Personnel w.e.f. August 14, 2026.
- Reported Q1 FY27 standalone revenue from operations of ₹10,277.32 Lacs (₹102.77 Cr), up 17.0% YoY.
- Q1 FY27 net profit grew 45.6% YoY to ₹1,429.61 Lacs (₹14.30 Cr) with basic EPS of ₹7.32.
- Resignation of internal auditor M/s Rushil Soni & Co. accepted w.e.f. August 14, 2026 due to other professional commitments.
One Global Service Provider reported a 17.0% YoY increase in standalone revenue from operations to Rs 102.77 Cr for Q1 FY27 compared to Rs 87.83 Cr in Q1 FY26, though revenue declined 23.2% sequentially from Rs 133.81 Cr in Q4 FY26. Standalone profit after tax (PAT) grew 45.6% YoY to Rs 14.30 Cr (vs. Rs 9.82 Cr in Q1 FY26), yielding an EPS of Rs 7.32. Operating margins held steady as purchase of stock in trade was Rs 80.17 Cr. Alongside results, the Board appointed CA Niraj Chordia as Chief Financial Officer and accepted the resignation of internal auditor Rushil Soni & Co.
- Standalone revenue from operations increased 17.0% YoY to Rs 10,277.32 Lakhs (Rs 102.77 Cr) in Q1 FY27
- Net profit (PAT) grew 45.6% YoY to Rs 1,429.61 Lakhs (Rs 14.30 Cr) vs Rs 981.90 Lakhs in Q1 FY26
- Basic and diluted EPS stood at Rs 7.32 for the quarter against Rs 5.02 in Q1 FY26
- Board approved the appointment of CA Niraj Chordia as Chief Financial Officer (CFO) w.e.f. August 14, 2026
- Internal Auditor M/s Rushil Soni & Co. resigned citing professional preoccupations
One Global Service Provider reported a 17.0% YoY increase in standalone revenue from operations to ₹102.77 Cr for Q1 FY27 (quarter ended June 30, 2026) compared to ₹87.83 Cr in Q1 FY26. Net profit rose 45.6% YoY to ₹14.30 Cr from ₹9.82 Cr, translating to a basic EPS of ₹7.32 (vs ₹5.02 in Q1 FY26). On a sequential basis, revenue and net profit declined by 23.2% and 21.4% respectively compared to Q4 FY26 (Revenue: ₹133.81 Cr, PAT: ₹18.19 Cr). Additionally, the Board appointed CA Niraj Chordia as Chief Financial Officer (CFO) and noted the resignation of internal auditor M/s Rushil Soni & Co.
- Revenue from operations grew 17.0% YoY to ₹10,277.32 Lacs in Q1 FY27 compared to ₹8,782.62 Lacs in Q1 FY26.
- Standalone Net Profit increased 45.6% YoY to ₹1,429.61 Lacs from ₹981.90 Lacs in the prior-year period.
- Basic EPS expanded to ₹7.32 for the quarter from ₹5.02 in Q1 FY26 (and ₹9.31 in Q4 FY26).
- Appointed CA Niraj Chordia as CFO and Key Managerial Personnel effective August 14, 2026.
One Global Service Provider Ltd has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company reported a significant revenue increase in FY26 to ₹498 Cr compared to ₹147 Cr in FY25, following its merger with Plus Care Internationals. With a current market capitalization of ₹895 Cr and a TTM PAT of ₹70 Cr, these results will be the first indicator of performance for the new fiscal year. The trading window for designated persons remains closed until 48 hours after the results are announced.
- Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results.
- Financials to cover the three-month period ended June 30, 2026.
- Trading window for insiders is currently closed as per SEBI PIT Regulations.
- Company reported TTM EPS of ₹44.34 leading up to this period.
Financial Performance
Revenue Growth by Segment
While absolute revenue figures are not disclosed, the Net Capital Turnover Ratio improved by 43.12% (from 5.96 to 8.53), indicating significantly higher revenue generation efficiency. The IT & Software Solutions segment is reported as seeing 'accelerated growth' compared to the 'foundational' Healthcare Services segment.
Geographic Revenue Split
Not disclosed in available documents, though the company mentions expansion into 'emerging markets' and 'underserved regions' for its healthcare screening services.
Profitability Margins
Net Profit Ratio improved from 0.08% to 0.11% YoY. While the margin remains thin, the Return on Equity (ROE) saw a substantial relative increase of 426%, rising from 0.19% to 1.00% for the financial year ended March 31, 2024.
EBITDA Margin
Core profitability as measured by Return on Capital Employed (ROCE) improved from 0.18% to 0.64%, representing a 255% YoY increase in capital efficiency.
Capital Expenditure
The company's paid-up capital increased by INR 12.44 Cr (from INR 7.10 Cr to INR 19.54 Cr) following the issuance of 1,24,38,296 equity shares for the amalgamation with Plus Care Internationals Private Limited.
Credit Rating & Borrowing
The Debt-wise Ratio (Debt-to-Equity) increased from 0.76 to 1.21, indicating a 59.2% increase in leverage to fund operations and the recent merger. Specific interest rates are not disclosed.
Operational Drivers
Raw Materials
As a service-oriented firm, the primary 'raw materials' are Human Capital (Specialist Physicians and IT Engineers) and Diagnostic Consumables for laboratory services.
Capacity Expansion
The company expanded its operational footprint through the merger with Plus Care Internationals Private Limited, which added 10,348 shares of the transferor company's value into the consolidated entity.
Raw Material Costs
Not disclosed in available documents; however, the company highlights 'attraction and retention of human capital' as a major cost-related risk.
Manufacturing Efficiency
Not applicable as a service provider; however, the Net Capital Turnover Ratio of 8.53 indicates high asset-light efficiency.
Strategic Growth
Growth Strategy
Growth is driven by a dual-segment strategy: 1) Consolidating healthcare through the Plus Care Internationals merger to scale mass screening and diagnostics. 2) Expanding the IT arm into high-demand sectors like e-commerce, banking, and biotechnology through digital transformation and cybersecurity services.
Products & Services
Mass screening, clinical diagnostics, laboratory support, software development, digital transformation consulting, cloud platforms, and cybersecurity solutions.
Brand Portfolio
One Global Service Provider, Plus Care Internationals.
New Products/Services
Expansion into AI-driven digital health and enterprise software solutions for the public sector diagnostics market.
Market Expansion
Targeting underserved regions for healthcare and global markets for IT-enabled services including cloud and data analytics.
Strategic Alliances
Amalgamation with Plus Care Internationals Private Limited, approved by NCLT on March 25, 2025.
External Factors
Industry Trends
The industry is shifting toward digital health (AI, cloud, data analytics). There is a rising global demand for scalable public health infrastructure and preventive care, which One Global is positioning for through its tech-driven diagnostics.
Competitive Landscape
Faces competition from both local players and multinational corporations in the healthcare and IT consulting sectors.
Competitive Moat
The company's moat is built on its 'dual-focus' model (Healthcare + IT) and its ability to attract specialist physicians. However, this is challenged by intense competition from multinational players and regulatory price caps.
Macro Economic Sensitivity
Highly sensitive to 'inflationary pressures' and 'slowdown in policy making' which affects the rollout of public health programs.
Consumer Behavior
Increased consumer and government focus on 'preventive care' and 'mass screening' is driving demand for the company's diagnostic services.
Regulatory & Governance
Industry Regulations
Subject to price controls and capping of margins on medicines by the government. Compliance with State and Central Healthcare coverage schemes impacts overall industry margins.
Legal Contingencies
The Hon’ble National Company Law Tribunal (NCLT), Mumbai Bench, passed an order on March 25, 2025, approving the Scheme of Amalgamation with Plus Care Internationals Private Limited.
Risk Analysis
Key Uncertainties
Regulatory changes in healthcare pricing (High impact), failure to fill key managerial vacancies like the CFO (Governance risk), and the risk of 'execution' on large institutional contracts.
Geographic Concentration Risk
Not disclosed, but operations are centered in India with a focus on Mumbai and Ahmedabad for corporate/secretarial functions.
Third Party Dependencies
Dependency on the National Company Law Tribunal for merger approvals and on institutional clients for healthcare revenue.
Technology Obsolescence Risk
The IT segment faces risks from rapid shifts in cloud and AI technologies, requiring continuous investment in innovation.
Credit & Counterparty Risk
Trade Receivables Turnover of 3.67 suggests a collection cycle of approximately 99 days, indicating moderate credit exposure to institutional clients.
